Drug information for RIMIFON
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
100MG/ML
Discontinued
ISONIAZID
Isoniazid
ROCHE
8420
INJECTABLE; INJECTION
25MG/ML
Discontinued
ISONIAZID
Isoniazid
ROCHE
"
SYRUP; ORAL
50MG/5ML
Discontinued
ISONIAZID
Isoniazid
ROCHE
"
Drug Adverse Effects information for RIMIFON
Role code
Indications
Reaction
# Reports
SS
ASPERGILLOSIS
CHOLESTASIS
1
SS
ASPERGILLOSIS
JAUNDICE
1
SS
BONE TUBERCULOSIS
HEPATITIS FULMINANT
6
SS
HEADACHE
HEPATITIS FULMINANT
2
SS
LUNG TRANSPLANT
CHOLESTASIS
2
SS
LUNG TRANSPLANT
JAUNDICE
2
SS
PULMONARY TUBERCULOSIS
CHOLESTASIS
2
SS
PULMONARY TUBERCULOSIS
JAUNDICE
2
C
ASPERGILLOSIS
DRUG INTERACTION
2
C
ASPERGILLOSIS
DRUG LEVEL INCREASED
2
C
ASPERGILLOSIS
RENAL FAILURE ACUTE
2
C
HEPATITIS C
RHABDOMYOLYSIS
1
C
HIV INFECTION
BICYTOPENIA
2
C
HIV INFECTION
FANCONI SYNDROME ACQUIRED
2
C
KERATITIS HERPETIC
ALTERNARIA INFECTION
4
C
KERATITIS HERPETIC
CHOLESTASIS
4
C
KERATITIS HERPETIC
GRANULOMA
4
C
KERATITIS HERPETIC
HEPATIC FUNCTION ABNORMAL
4
C
KERATITIS HERPETIC
HEPATOTOXICITY
4
C
KERATITIS HERPETIC
LUNG DISORDER
4
C
KERATITIS HERPETIC
MYCOBACTERIUM KANSASII INFECTION
4
C
KERATITIS HERPETIC
SKIN LESION
4
C
KERATITIS HERPETIC
TRANSAMINASES INCREASED
4
C
LATENT TUBERCULOSIS
BICYTOPENIA
1
C
LATENT TUBERCULOSIS
FANCONI SYNDROME ACQUIRED
1
C
LUNG TRANSPLANT
DRUG INTERACTION
2
C
LUNG TRANSPLANT
DRUG LEVEL INCREASED
2
C
LUNG TRANSPLANT
RENAL FAILURE ACUTE
2
C
MYCOBACTERIAL INFECTION
RHABDOMYOLYSIS
4
C
MYCOBACTERIUM KANSASII INFECTION
ALTERNARIA INFECTION
3
C
MYCOBACTERIUM KANSASII INFECTION
CHOLESTASIS
3
C
MYCOBACTERIUM KANSASII INFECTION
GRANULOMA
3
C
MYCOBACTERIUM KANSASII INFECTION
HEPATIC FUNCTION ABNORMAL
3
C
MYCOBACTERIUM KANSASII INFECTION
HEPATOTOXICITY
3
C
MYCOBACTERIUM KANSASII INFECTION
LUNG DISORDER
3
C
MYCOBACTERIUM KANSASII INFECTION
MYCOBACTERIUM KANSASII INFECTION
3
C
MYCOBACTERIUM KANSASII INFECTION
SKIN LESION
3
C
MYCOBACTERIUM KANSASII INFECTION
TRANSAMINASES INCREASED
3
C
OPPORTUNISTIC INFECTION PROPHYLAXIS
DRUG INTERACTION
1
C
OPPORTUNISTIC INFECTION PROPHYLAXIS
DRUG LEVEL INCREASED
1
C
OPPORTUNISTIC INFECTION PROPHYLAXIS
RENAL FAILURE ACUTE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
ALTERNARIA INFECTION
6
C
PRODUCT USED FOR UNKNOWN INDICATION
CHOLESTASIS
6
C
PRODUCT USED FOR UNKNOWN INDICATION
GRANULOMA
6
C
PRODUCT USED FOR UNKNOWN INDICATION
HEPATIC FUNCTION ABNORMAL
6
C
PRODUCT USED FOR UNKNOWN INDICATION
HEPATOTOXICITY
6
C
PRODUCT USED FOR UNKNOWN INDICATION
LUNG DISORDER
6
C
PRODUCT USED FOR UNKNOWN INDICATION
MYCOBACTERIUM KANSASII INFECTION
6
C
PRODUCT USED FOR UNKNOWN INDICATION
RHABDOMYOLYSIS
8
C
PRODUCT USED FOR UNKNOWN INDICATION
SKIN LESION
6
C
PRODUCT USED FOR UNKNOWN INDICATION
TRANSAMINASES INCREASED
6
C
RESPIRATORY TRACT INFECTION
RHABDOMYOLYSIS
4
C
SUBSTANCE ABUSE
RHABDOMYOLYSIS
1
C
TUBERCULOSIS
DRUG INTERACTION
2
C
TUBERCULOSIS
DRUG LEVEL INCREASED
2
C
TUBERCULOSIS
RENAL FAILURE ACUTE
2
Ads by Google